Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials - The Lancet Oncology
Despite Equivalent Outcomes, Men Receive Neoadjuvant Chemotherapy Less Often Than Women for Lymph Node-Positive Breast Cancer | SpringerLink
Discrepancy of Breast and Axillary Pathologic Complete Response and Outcomes in Different Subtypes of Node-positive Breast Cancer after Neoadjuvant Chemotherapy
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology
náhoda nebezpečenstvo príjem overall outcome after neoadjuvant chemotherapy filter odhad optimálna
Treatment outcome in patients with stage III breast cancer treated with neoadjuvant chemotherapy
Long-term Results After Neoadjuvant Chemotherapy for Breast Cancer: A Single-center Experience | Anticancer Research
Imaging, biomarkers after first neoadjuvant chemotherapy treatment cycle predicts treatment outcome, study finds | McKelvey School of Engineering at Washington University in St. Louis
Cancers | Free Full-Text | Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer
Pathologic Complete Response: Understanding the Subtleties - The ASCO Post
Outcome after neoadjuvant chemotherapy in Asian breast cancer patients – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.
MRI to assess response after neoadjuvant chemotherapy in breast cancer subtypes: a systematic review and meta-analysis | npj Breast Cancer
Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome | Nature Communications
Cancers | Free Full-Text | Post-Neoadjuvant Treatment Strategies for Patients with Early Breast Cancer
Neoadjuvant chemotherapy increases rates of breast-conserving surgery in early operable breast cancer | HKMJ
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer | NEJM
Mechanisms of Resistance to Neoadjuvant Chemotherapy in Breast Cancer | NEJM
Comparing outcomes following total neoadjuvant therapy and following neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer - eClinicalMedicine
Survival outcomes after neoadjuvant letrozole and palbociclib versus third generation chemotherapy for patients with high-risk oestrogen receptor-positive HER2-negative breast cancer - ScienceDirect
Clinical outcomes with neoadjuvant versus adjuvant chemotherapy for triple negative breast cancer: A report from the National Cancer Database | PLOS ONE
Cancers | Free Full-Text | Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision Medicine
Novel Neoadjuvant Treatment Strategies for Triple-Negative Breast Cancer
Neoadjuvant Chemotherapy for Breast Cancer - Unanswered Questions - HealthManagement.org
Comparison of outcomes between neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy in patients with locally advanced esophageal cancer: A network meta-analysis - eClinicalMedicine
Frontiers | Advances in Imaging in Evaluating the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer
